Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data

Aim We aimed to develop an application to calculate mean amplitude of glycaemic excursions (MAGE) automatically and to evaluate its accuracy. Materials and Methods We named the application intermittently scanned continuous glucose monitoring (isCGM) calculator KAMOGAWA (Kyoto Auto MAGE Of Glucose cA...

Full description

Saved in:
Bibliographic Details
Published inDiabetes, Obesity and Metabolism Vol. 23; no. 9; pp. 2155 - 2160
Main Authors Kitae, Aya, Kimura, Tetsuya, Munekawa, Chihiro, Hosomi, Yukako, Osaka, Takafumi, Kitagawa, Noriyuki, Ushigome, Emi, Yamazaki, Masahiro, Hamaguchi, Masahide, Fukui, Michiaki
Format Journal Article
LanguageEnglish
Published Oxford, UK Wiley 01.09.2021
Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aim We aimed to develop an application to calculate mean amplitude of glycaemic excursions (MAGE) automatically and to evaluate its accuracy. Materials and Methods We named the application intermittently scanned continuous glucose monitoring (isCGM) calculator KAMOGAWA (Kyoto Auto MAGE Of Glucose cAlcutator With isCGM Application). The isCGM data from 20 patients, 10 with and 10 without diabetes, were used to compare manually calculated MAGE values with those calculated using KAMOGAWA. The rate of agreement for the MAGE values was calculated. Results Comparing the MAGE values calculated manually with those calculated using KAMOGAWA, the total mean rate of agreement was 81.6%. Nonmatching values were checked and it was found that the inconsistencies were all attributable to errors in manual calculations. After correcting errors in the manual calculation, the MAGE values matched to one decimal place for all data in the manual and KAMOGAWA calculations. Conclusions KAMOGAWA can help diabetologists use MAGE in clinical practice, which could contribute to improving glycaemic control in patients who use isCGM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1462-8902
1463-1326
1463-1326
DOI:10.1111/dom.14457